Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors

Krista L. Lentine, Mark A. Schnitzler, Huiling Xiao, David Axelrod, Amit X. Garg, Janet E. Tuttle-Newhall, Daniel C. Brennan, Dorry L. Segev

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


BACKGROUND: Racial disparities in health outcomes after living donation have been reported, but generalizability is not known. METHODS: We linked Organ Procurement and Transplantation Network (OPTN) registry data for 4,007 living kidney donors in 1987 to 2008 with Medicare billing claims (2000-2008). Cox regression with left and right censoring was used to estimate the frequencies and relative risks of postdonation medical diagnoses according to race. Patterns were compared with findings from a previous linkage of OPTN donor records and private insurance claims. RESULTS: Among the Medicare-insured donors, 8% were African American and 5.7% were Hispanic. Diagnosis frequencies at 5 years after donation in the Medicare-versus privately insured donors included the following: malignant hypertension, 5.0% versus 0.9%; diabetes, 18.5% versus 4.1%; and chronic kidney disease, 21.8% versus 4.9%. After age and sex adjustment in the Medicare sample, African Americans, as compared with white donors, experienced higher risks of any hypertension diagnosis, including 2.4 times the likelihood of malignant hypertension (adjusted hazard ratio [aHR], 2.35; 95% confidence interval [CI], 1.40-3.93), and more common diabetes (aHR, 1.50; 95% CI, 1.12-2.04), chronic kidney disease (aHR, 1.84; 95% CI, 1.37-2.47), and proteinuria (aHR, 2.44; 95% CI, 1.45-4.11) diagnoses. Relative patterns for privately insured African American versus white donors were similar, including approximately three times the risk of malignant hypertension (aHR, 3.27; 95% CI, 1.82-5.88) and twice the relative risks of chronic kidney disease and proteinuria. CONCLUSIONS: Consistent demonstration of racial variation in postdonation medical conditions regardless of sample/payer source supports the need for continued study of mediators and consequences of outcomes in non-white donors.

Original languageEnglish (US)
Pages (from-to)316-324
Number of pages9
Issue number3
StatePublished - Feb 15 2014


  • Chronic kidney disease
  • Diabetes mellitus
  • Hypertension
  • Kidney transplantation
  • Living donors,Medicare

ASJC Scopus subject areas

  • Transplantation


Dive into the research topics of 'Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors'. Together they form a unique fingerprint.

Cite this